Evaluation of the diagnostic performance of four self-tests for vulvovaginal candidiasis
The investigated self-tests demonstrated varying performances, with both sensitivity and specificity being consistently lower than manufacturer claims. These findings underscore the urgent need for developing and validating more reliable self-tests to support adequate management of women's health. The sensitivity of currently marketed tests is only slightly better than empirical or self-diagnosis, which limits their clinical utility.
Authors
- Sylvia Maria Bruisten (ORCID: https://orcid.org/0000-0003-4897-4261)
- Lisa Himschoot (ORCID: https://orcid.org/0000-0002-4822-9272)
- Piet Cools (ORCID: https://orcid.org/0000-0003-2980-5307)
- Nathan das Neves Selis (ORCID: https://orcid.org/0000-0001-8672-7590)
- Daphné A. Schmid (ORCID: https://orcid.org/0000-0002-9735-2787)
- Aylien Vanraepenbusch
- Paul Meakin
- Yevgeniy Blumin
Institutions
- Ghent University (BE)
- Bayer (Switzerland) (CH)
- Blue Earth Diagnostics (United Kingdom) (GB)
- GGD Amsterdam (NL)
Publication Details
- Journal
- Sexually Transmitted Infections
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1136/sextrans-2025-056642
- Citations
- 1
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.18